Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
Provident Healthcare Partners Provident Healthcare Partners

Transaction Structures in the COVID-19 Era

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Published May 2020

At the outset of the COVID-19 pandemic, Provident published a white paper, COVID-19 ’s Impact on Investment Consolidation within Healthcare Services detailing how COVID-19 was impacting M&A trends within the healthcare services market. Much of the economic turmoil depicted in the previous white paper has held to be true unemployment has skyrocketed, M&A activity has slowed significantly, and first quarter earnings announcements have shown that even the United States’ largest companies like Amazon and Apple were not immune to the adverse impacts of COVID-19. Amidst all of this uncertainty, however, several transactions have still been completed. Transactions that have closed have necessitated flexibility from both buyers and sellers in order to arrive at creative transaction structures to push deals over the finish line. This white paper will delve further into these structures being used to complete M&A transactions and private equity recapitalizations in the COVID-19 environment.

Report Summary

• Introduction
• Why Do Transaction Structures Have to Change?
• What Are The Transaction Structures Being Used?
• Concluding Thoughts

Provide your information below to access this document.
Name(Required)